KRYS
Price
$184.19
Change
-$1.87 (-1.01%)
Updated
Sep 6 closing price
58 days until earnings call
NVCT
Price
$6.18
Change
+$0.02 (+0.32%)
Updated
Sep 6 closing price
60 days until earnings call
Ad is loading...

KRYS vs NVCT

Header iconKRYS vs NVCT Comparison
Open Charts KRYS vs NVCTBanner chart's image
Krystal Biotech
Price$184.19
Change-$1.87 (-1.01%)
Volume$92.81K
CapitalizationN/A
Nuvectis Pharma
Price$6.18
Change+$0.02 (+0.32%)
Volume$117.23K
CapitalizationN/A
View a ticker or compare two or three
KRYS vs NVCT Comparison Chart
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
KRYS vs. NVCT commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a StrongSell and NVCT is a Hold.

COMPARISON
Comparison
Sep 08, 2024
Stock price -- (KRYS: $186.31 vs. NVCT: $6.16)
Brand notoriety: KRYS and NVCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 31% vs. NVCT: 285%
Market capitalization -- KRYS: $5.29B vs. NVCT: $115.27M
KRYS [@Biotechnology] is valued at $5.29B. NVCT’s [@Biotechnology] market capitalization is $115.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $584.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 1 FA rating(s) are green whileNVCT’s FA Score has 0 green FA rating(s).

  • KRYS’s FA Score: 1 green, 4 red.
  • NVCT’s FA Score: 0 green, 5 red.
According to our system of comparison, KRYS is a better buy in the long-term than NVCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 6 TA indicator(s) are bullish while NVCT’s TA Score has 4 bullish TA indicator(s).

  • KRYS’s TA Score: 6 bullish, 4 bearish.
  • NVCT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than NVCT.

Price Growth

KRYS (@Biotechnology) experienced а -4.56% price change this week, while NVCT (@Biotechnology) price change was -9.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.71%. For the same industry, the average monthly price growth was +3.67%, and the average quarterly price growth was -3.87%.

Reported Earning Dates

KRYS is expected to report earnings on Nov 04, 2024.

NVCT is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (-2.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($5.29B) has a higher market cap than NVCT($115M). KRYS YTD gains are higher at: 50.177 vs. NVCT (-26.139). KRYS has higher annual earnings (EBITDA): 120M vs. NVCT (-22.06M). KRYS has more cash in the bank: 560M vs. NVCT (18.1M). KRYS has higher revenues than NVCT: KRYS (166M) vs NVCT (0).
KRYSNVCTKRYS / NVCT
Capitalization5.29B115M4,602%
EBITDA120M-22.06M-544%
Gain YTD50.177-26.139-192%
P/E Ratio46.63N/A-
Revenue166M0-
Total Cash560M18.1M3,094%
Total Debt7.69MN/A-
FUNDAMENTALS RATINGS
KRYS: Fundamental Ratings
KRYS
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
5
SMR RATING
1..100
59
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KRYSNVCT
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
77%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
N/A
View a ticker or compare two or three
Ad is loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TOLZ50.240.23
+0.45%
ProShares DJ Brookfield Global Infras
KNCT96.80-0.02
-0.03%
Invesco Next Gen Connectivity ETF
CLOI52.78-0.08
-0.16%
VanEck CLO ETF
TECL70.86-0.32
-0.45%
Direxion Daily Technology Bull 3X ETF
SYNB31.83-0.23
-0.72%
Putnam BioRevolution ETF

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
+0.19%
BEAM - KRYS
49%
Loosely correlated
+0.46%
ORMP - KRYS
48%
Loosely correlated
-3.36%
RXRX - KRYS
47%
Loosely correlated
+1.15%
CLDX - KRYS
47%
Loosely correlated
-2.38%
NTLA - KRYS
46%
Loosely correlated
-1.55%
More